For example, EMX2 has been demonstrated as a tumor suppressor in lung cancer, and low EMX2 expression is associated with decreased overall survival and recurrence free survival in patients with lung adenocarcinomas [22], [23]. This evidence concerns the gene EMX2 and lung cancer.